๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Gastric Cancer (GC)

Multimodal Prehabilitation in Gastric Cancer Patients NCT07839702NA1 site๐Ÿ“ Singapore National University Hospital, Singapore ยท Tests: prehabilitation A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites๐Ÿ“ Goodyear๐Ÿ“ Phoenix๐Ÿ“ Duarte IDEAYA Biosciences ยท Tests: IDE892, IDE397 BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. NCT06773312Phase 11 site๐Ÿ“ Beijing Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. ยท Tests: BC001+Sintilimab+XELOX A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) Phase 2 Trial of KN026+KN046ยฑXELOX in HER2-positive Locally Advanced GC NCT06023758Phase 21 site๐Ÿ“ Beijing Peking University ยท Tests: KN026, KN046, XELOX The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer NCT07183150n/a1 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer NCT07635836NA1 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Double-tract reconstruction A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma NCT07069712Phase 270 sites๐Ÿ“ Newark๐Ÿ“ Washington D.C.๐Ÿ“ Fairway AstraZeneca ยท Tests: Sonesitatug Vedotin, Rilvegostomig, Trastuzumab Deruxtecan (T-DXd), Capecitabine, 5-Fluorouracil (5-FU) SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites๐Ÿ“ Glen Burnie๐Ÿ“ Pittsburgh๐Ÿ“ Seoul SK Life Science, Inc. ยท Tests: SKL35501, SKL35502 The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies NCT07770126n/a3 sites๐Ÿ“ Edegem๐Ÿ“ Ghent๐Ÿ“ Kortrijk Universiteit Antwerpen SHR-1701 + Rivoceranib (ยฑ SHR-2554) in Advanced GC After First-Line Immunotherapy Failure NCT07311408Phase 21 site๐Ÿ“ Shenyang Jingdong Zhang ยท Tests: SHR-1701+Rivoceranib + SHR-2554, SHR-1701 + Rivoceranib Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer NCT06687291n/a1 site๐Ÿ“ Huddinge Karolinska Institutet Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC NCT04342910Phase 31 site๐Ÿ“ Beijing Jiangsu HengRui Medicine Co., Ltd. ยท Tests: camrelizumab, Apatinib Mesylate, Paclitaxel, Irinotecan Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. NCT07217704Phase 319 sites๐Ÿ“ Cerritos๐Ÿ“ Duarte๐Ÿ“ Irvine SOFIE ยท Tests: [18F]FAPI-74 PET/CT Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers NCT07243015n/a1 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: small RNA-seq or array, ENLIGHT Assay Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer NCT07587229n/a1 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Observational study (no intervention) A Study of SH009 Injection in Patients With Advanced Solid Tumors. NCT07390838Phase 11 site๐Ÿ“ Shanghai Nanjing Sanhome Pharmaceutical, Co., Ltd. ยท Tests: SH009 Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens NCT06572319Phase 1, Phase 21 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: Disitamab Vedotin(RC48) Plus Tratuzumab Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore NCT06157996Phase 21 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: lenvatinib and tislelizumab plus CapeOX chemotherapy, tislelizumab plus CapeOX chemotherapy Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM NCT06341595Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Sintilimab, Extraperitoneal radiation therapy, Oxaliplatin, S-1 Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer NCT07366528Phase 35 sites๐Ÿ“ Shaoguan๐Ÿ“ Shanghai๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Oxaliplatin plus S-1, Docetaxel plus S-1 Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach NCT04022109n/a5 sites๐Ÿ“ Sรฃo Paulo๐Ÿ“ Santiago๐Ÿ“ Bogotรก University of Latvia ยท Tests: Breath sampling for VOC detection, Surgery material collection for VOC headspace analysis, Upper endoscopy, Microbiota โ€ฆ Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer NCT07689851Phase 23 sites๐Ÿ“ Shenzhen๐Ÿ“ Taiyuan๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: COPOX, Radiotherapy, SHR-1701 Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients NCT06650332Phase 1, Phase 21 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: cadonilimab, Trastuzumab, XELOX, Disitamab Vedotin, mFOLFOX6 Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites NCT07855640n/a1 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer๏ผšMetBio-GC NCT07076979n/a1 site๐Ÿ“ Shanghai Shanghai Minimally Invasive Surgery Center A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites๐Ÿ“ Phoenix๐Ÿ“ San Francisco๐Ÿ“ Hartford BioNTech SE ยท Tests: BNT326, Pumitamig, Itraconazole, Paroxetine A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) NCT06506292Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Adebrelimab, XELOX PPG vs. ICG in Gastrointestinal Resections NCT06222645NA3 sites๐Ÿ“ Yantai๐Ÿ“ Saint Petersburg๐Ÿ“ Saint Petersburg Saint Petersburg State University, Russia ยท Tests: ICG fluorescence imaging technology, Imaging Photoplethysmography System A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ยฑ Adebrelimab in Treating Advanced Second-line Gastric Cancer NCT07770113Phase 21 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: Adebrelimab, Apatinib, Albumin-bound paclitaxel
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy